• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.32% Nasdaq Up 0.32%

    RXi Pharmaceuticals Corporation (RXII)

    -NasdaqCM
    0.39 Up 0.02(4.84%) 12:45PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.37
    Open:0.39
    Bid:0.39 x 1600
    Ask:0.39 x 3600
    1y Target Est:3.63
    Beta:3.21
    Earnings Date:Aug 12 - Aug 17 (Est.)
    Day's Range:0.38 - 0.39
    52wk Range:0.34 - 3.98
    Volume:4,562,581
    Avg Vol (3m):1,354,400
    Market Cap:14.17M
    P/E (ttm):N/A
    EPS (ttm):-0.63
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RXII

    Comparison

    Symbol% ChgMkt Cap
    RXIIUp 4.84%14.17M
    ALNYDown 2.36%10.81B
    MRNADown 6.19%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):153.52
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.30
    Quarterly EPS Est (Jun-15) :-0.09
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback